Mutant RAS-driven Secretome Causes Skeletal Muscle Defects in Breast Cancer.

Mutant RAS- and PIK3CA-driven breast cancers distinctly affect the function of skeletal muscle. Therefore, research and therapeutic targeting of cancer-induced systemic effects need to take aberrant cancer genome into consideration.